PCED1B and central nervous system cancer: Practical experiments illustrated that PCED1B-AS1's gene silencing repressed the proliferation of glioma cells and induced apoptosis, indicating that PCED1B-AS1 provided an auspicious biomarker for the prognosis, as well as drug targets of glioma [58, 59].